Introduction Part 1--Conceptual Framework Chapter 1--Conceptual Framework for Prescribing Psychotropic Medications Background Rationale for Conceptual Framework Group 1 Medications for ADHD, Anxiety, and Depression Specific Rationale Group 2 Medications Group 3 Medications Part 2--Practical Guidance Chapter 2--Assessment Overview General Clinical Guidance Assessment Formulation and Feedback Chapter 3--Prescribing Medications: Getting Started Part 3--Group 1 Medications for Specific Diagnoses: ADHD, Anxiety, and Depression Chapter 4--Group 1 Medications for Attention-Deficit/Hyperactivity Disorder General Guidance Methylphenidate Preparations Amphetamine Preparations Guanfacine Preparations Clonidine Preparations Atomoxetine Summary Chapter 5--Group 1 Medications for Anxiety and Depression General Guidance General Guidance Group 1 Selective Serotonin Reuptake Inhibitors Summary Part 4--Group 2 (FDA-Approved Antipsychotics and Mood Stabilizers) and Group 3 (All Other) Medications Chapter 6--Group 2 Medications: Antipsychotics and Mood Stabilizer Rationale Antipsychotics The Mood Stabilizer Lithium Summary Chapter 7--Group 3 Medications Other Antidepressants Other Antipsychotics Other Mood Stabilizers Anxiolytics Sleep Aids Futures Considerations Part 5--Advanced Topics Chapter 8--What to Do When Treatment Is Not Successful The Limits of Evidence-Based Treatments and Protocols Reassess Diagnoses Incomplete or Inaccurate Reports Phenomenological or Nosologic Issues Reassess Non-diagnostic Issues and Concerns Reconsider Psychotherapy(ies) or Therapist Reconsider Medication When to Consider Group 2 Antipsychotics or Lithium When to Consider Group 3 Medications Without FDA Approval for Use in Youth When to Consider Drug Levels or Genetic Testing When to Consider Consultation or a Second Opinion When to Consider Referral for All or Part of the Patient's Ongoing Behavioral Care Appendixes Appendix A--Assessment and Symptom Monitoring Tools Appendix B--Resources for Clinicians Appendix C--Training Resources for Clinicians Appendix D--Quality Ratings for Psychotherapies and Efficacy Data for Medications Appendix E--Resources for Caregivers Appendix F--Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Complete Criteria of Select Diagnosis Index.